Category Archives: Patent examination system

Govt. draws flak for decision to allow U.S.- trained patent examiners

By Vidya Krishnan, The Hindu | March 30, 2016 Humanitarian aid organisation Médecins Sans Frontières (Doctors Without Borders) has questioned the Indian government’s decision to have patent officers trained by the United States Patent & Trademark Office after the recent … Continue reading

Posted in Indian Patent Law, Patent examination system, Uncategorized | Leave a comment

South Africa Awaits Patent Reforms With Hope, Concern

Source: IP Watch 2 March 2015 CAPE TOWN – South Africa’s new policy on patents could go to the Cabinet for approval soon, says Doctors without Borders (Médecins Sans Frontières, MSF), one of the organisations spearheading the Fix the Patent … Continue reading

Posted in Evergreening, Fix the patent law, Patent examination system | Leave a comment

Obama Versus Obamacare

Source: Project Syndicate 12 Feb 2015 NEW YORK – The US Patient Protection and Affordable Care Act, President Barack Obama’s signature 2010 health-care reform, has succeeded in extending insurance coverage to millions of Americans who would not otherwise have it. … Continue reading

Posted in Hepatitis C, Indian Patent Law, IPR policy, Patent examination system, TRIPS, US pressure on India | Leave a comment

US pharma gets a booster shot

Source: Business Line Thanks to the India-US Intellectual Property Working Group. Here’s how — and why this is bad news for India’s poor Prime Minister Narendra Modi’s first official visit to the US included several meetings with industry representatives and … Continue reading

Posted in BRICS, Compulsory Licensing, FDI, Generics, Innovation, IP Rights, IPR policy, Patent examination system, Patent Term Extension, Pricing, US pressure on India, USTR 301 report, WTO | Tagged , , | Leave a comment

Dear Prime Minister Modi: Stand firm for affordable medicines

Source: South Asia Foreign Policy As Prime Minister Narendra Modi makes his first official visit to the United States, one issue at the top of the trade agenda is the strikingly different approaches of the Indian and U.S. governments toward … Continue reading

Posted in Compulsory Licensing, Generics, IPR policy, Patent examination system, Patents, Right to Health, Sec 3 (d), USTR 301 report, WTO | Leave a comment

Modi Visit Unlikely To Yield Major Outcomes On Trade, Economic Issues

Source: World Trade Online September 29,2014 Senior administration officials have made clear that Indian Prime Minister Narendra Modi’s Sept. 29-30 trip to Washington is not expected to yield major outcomes on trade issues when they omitted them from the list … Continue reading

Posted in Investment treaties, IP Rights, IPR policy, Patent examination system, Patents, Sec 3 (d) | Tagged , , , | 1 Comment

F.D.A. Approves Pill to Treat Hepatitis C

Source: New York Times Tom Espinosa, a building inspector in Oakland, Calif, has tried the existing drugs for hepatitis C and some experimental ones, without success. THOR SWIFT FOR THE NEW YORK TIMES The Food and Drug Administration on Friday … Continue reading

Posted in FDI, Hepatitis C, HIV/Aids, IP Rights, Patent examination system, Patents, Pricing, Right to Health | Tagged , | Leave a comment